Opthea Limited (OPT.AX)
AUD 0.66
(1.54%)
AUD 0.66
(1.54%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 141.64 Million USD | 51789.02% |
| 2023 | 272.98 Thousand USD | 0.0% |
| 2022 | - USD | -100.0% |
| 2021 | 150.46 Thousand USD | -43.24% |
| 2020 | 265.07 Thousand AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | -100.0% |
| 2005 | 3.81 Million AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| 2002 | - AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | -100.0% |
| 1997 | 2859.00 AUD | -72.07% |
| 1996 | 10.23 Thousand AUD | 0.0% |
| 1995 | - AUD | 0.0% |
| 1994 | - AUD | -100.0% |
| 1993 | 668.00 AUD | -96.69% |
| 1992 | 20.16 Thousand AUD | 162.98% |
| 1991 | 7669.01 AUD | 0.0% |
| 1990 | - AUD | 0.0% |
| 1989 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 129.83 Thousand USD | 0.0% |
| 2024 FY | 141.64 Million USD | 51789.02% |
| 2024 Q4 | 141.64 Million USD | 0.0% |
| 2023 FY | 272.98 Thousand USD | 0.0% |
| 2023 Q4 | 272.98 Thousand USD | 0.0% |
| 2023 Q2 | 130.04 Million USD | 0.0% |
| 2022 FY | - USD | -100.0% |
| 2022 Q2 | 92.49 Thousand USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q2 | 205.89 Thousand USD | 0.0% |
| 2021 Q4 | 112.96 Thousand USD | 0.0% |
| 2021 FY | 150.46 Thousand USD | -43.24% |
| 2020 FY | 265.07 Thousand AUD | 0.0% |
| 2020 Q4 | 265.07 Thousand AUD | 0.0% |
| 2020 Q2 | 386.25 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 FY | - AUD | -100.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2005 FY | 3.81 Million AUD | 0.0% |
| 2005 Q4 | 3.81 Million AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2002 FY | - AUD | 0.0% |
| 2002 Q4 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1998 FY | - AUD | -100.0% |
| 1997 Q4 | 2154.55 AUD | 0.0% |
| 1997 FY | 2859.00 AUD | -72.07% |
| 1996 FY | 10.23 Thousand AUD | 0.0% |
| 1995 FY | - AUD | 0.0% |
| 1994 FY | - AUD | -100.0% |
| 1993 FY | 668.00 AUD | -96.69% |
| 1992 FY | 20.16 Thousand AUD | 162.98% |
| 1991 FY | 7669.01 AUD | 0.0% |
| 1990 FY | - AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -114264.816% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | -2405.49% |
| Biome Australia Limited | 1.3 Million AUD | -10748.252% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | -20437.788% |
| Imugene Limited | 1.54 Million AUD | -9056.714% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | -12629.035% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -42760.42% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -44669.256% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.224% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | -16000.28% |
| Starpharma Holdings Limited | 3.52 Million AUD | -3914.957% |
| Nanollose Limited | 42.53 Thousand AUD | -332953.576% |
| Memphasys Limited | 4.41 Million AUD | -3109.656% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | -8969.985% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | -33468.348% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | -711.967% |
| Dimerix Limited | 149.68 Thousand AUD | -94531.779% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | -11432.311% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -88961.389% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | -9425.735% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -1986543.562% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | -5578.268% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -600305.587% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -59085.094% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -17361.715% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -80771.754% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -44294.061% |
| Immuron Limited | 173.49 Thousand AUD | -81542.729% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |